2-methyl-6-[4-(1-propan-2-ylimidazol-4-yl)sulfonylpiperazin-1-yl]-N-pyridin-2-ylpyrimidin-4-amine
C20H26N8O2S — CID 122350088
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methyl-6-[4-(1-propan-2-ylimidazol-4-yl)sulfonylpiperazin-1-yl]-N-pyridin-2-ylpyrimidin-4-amine
2-methyl-6-[4-(1-propan-2-ylimidazol-4-yl)sulfonylpiperazin-1-yl]-N-pyridin-2-ylpyrimidin-4-amine (PubChem CID 122350088) has the molecular formula C20H26N8O2S and a molecular weight of 442.55 g/mol. Its IUPAC name is 2-methyl-6-[4-(1-propan-2-ylimidazol-4-yl)sulfonylpiperazin-1-yl]-N-pyridin-2-ylpyrimidin-4-amine.
Molecular Properties
| Compound Name | 2-methyl-6-[4-(1-propan-2-ylimidazol-4-yl)sulfonylpiperazin-1-yl]-N-pyridin-2-ylpyrimidin-4-amine |
|---|---|
| PubChem CID | 122350088 |
| Molecular Formula | C20H26N8O2S |
| Molecular Weight | 442.55 g/mol |
| Exact Mass | 442.19 |
| IUPAC Name | 2-methyl-6-[4-(1-propan-2-ylimidazol-4-yl)sulfonylpiperazin-1-yl]-N-pyridin-2-ylpyrimidin-4-amine |
| SMILES | Cc1nc(Nc2ccccn2)cc(N2CCN(S(=O)(=O)c3cn(C(C)C)cn3)CC2)n1 |
| InChI | InChI=1S/C20H26N8O2S/c1-15(2)27-13-20(22-14-27)31(29,30)28-10-8-26(9-11-28)19-12-18(23-16(3)24-19)25-17-6-4-5-7-21-17/h4-7,12-15H,8-11H2,1-3H3,(H,21,23,24,25) |
| InChIKey | NSTMOQGTUMLOAI-UHFFFAOYSA-N |
| XLogP | 2.21 |
| TPSA | 109.14 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 442.55 |
| LogP ≤ 5 | 2.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122350088 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.